Skip to main content
. 2023 Apr 3;15(8):2937–2969. doi: 10.18632/aging.204619

Figure 12.

Figure 12

The correlation of drug sensitivity and cancer pathway activity about FARSB in HCC patients. (A) FARSB-related cancer pathway activity. (B) FARSB-related drug sensitivity using GDSC.